Detection ofCSF1rearrangements deleting the 3′ UTR in tenosynovial giant cell tumors-Reference-Cited by-同舟云学术

Detection ofCSF1rearrangements deleting the 3′ UTR in tenosynovial giant cell tumors

Published:2019-09-12 Issue:2 Volume:59 Page:96-105
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Ho Julie¹,Peters Thomas²,Dickson Brendan C.³^ORCID,Swanson David³,Fernandez Anita²,Frova‐Seguin Aurelie²,Valentin Marie‐Anne²,Schramm Ursula²,Sultan Marc²,Nielsen Torsten O.¹,Demicco Elizabeth G.³^ORCID

Affiliation:

1. Genetic Pathology Evaluation Centre, University of British Columbia Vancouver British Columbia Canada

2. Novartis Institute for Biomedical Research Basel Switzerland

3. Department of Pathology and Laboratory MedicineMount Sinai Hospital Toronto Ontario Canada

Funder

Canadian Cancer Society Research Institute

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/gcc.22807

Reference48 articles.

1. Chromosome aberrations in tenosynovial giant cell tumors and nontumorous synovial tissue

2. Diffuse-variant tenosynovial giant cell tumor: A rare and aggressive lesion

3. Cytogenetic characterization of tenosynovial giant cell tumors (nodular tenosynovitis);Dal Cin P;Cancer Res,1994

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arthroscopic Excision of a Localized Tenosynovial Giant Cell Tumor of the Knee: A Case Report;Current Rheumatology Reviews;2024-09

2. Soft‐Tissue Tumours and Tumour‐Like Conditions;Rook's Textbook of Dermatology;2024-03-19

3. Pathology of intra-articular tumours and tumour-like lesions: pearls, pitfalls and rarities from a general surgical pathology practice;Skeletal Radiology;2024-02-16

4. MOLECULAR PATHWAYS AND THERAPEUTIC STRATEGIES IN DERMATOFIBROSARCOMA PROTUBERANS (DFSP): UNRAVELLING THE TUMOR'S GENETIC LANDSCAPE;EXCLI J;2024

5. CSF1 expression in xanthogranulomatous epithelial tumor/keratin-positive giant cell-rich tumor;Human Pathology;2024-01